Basic Tofranil Information

• INN (International Nonproprietary Name): Imipramine
• Brand Names Available In Canada (English): Tofranil® is the widely recognised brand and generic imipramine hydrochloride or imipramine pamoate are commonly supplied.
• ATC Code: N06AA02 (Non-selective monoamine reuptake inhibitor; tricyclic antidepressant)
• Forms & Dosages: Tablets 10 mg, 25 mg, 50 mg (imipramine hydrochloride); Capsules 75 mg, 100 mg, 125 mg, 150 mg (imipramine pamoate).
• Manufacturers In Canada (English): Novartis is the originator for Tofranil; multiple generic manufacturers supply imipramine products globally (examples: Teva, Mylan, Sandoz).
• Registration Status In Canada (English): Not specified in the provided data for a Canada-specific registration entry.
• OTC / Rx Classification: Prescription Only (Rx).

Important instructions & quick warnings for Canadian patients (do not treat as medical advice):

Always fill a prescription through a licensed Canadian pharmacy that dispenses products with a valid DIN.

Keep Tofranil/imipramine out of children’s reach and store tablets or capsules at 20–25°C (68–77°F) away from moisture and light.

Do not stop imipramine suddenly; withdrawal symptoms can occur with abrupt discontinuation.

In an overdose or severe side effect such as seizures, fainting, or chest pain, call 911 or Poison Control (Canada: 1-800-268-9017) immediately.

Discuss provincial coverage (Ontario Drug Benefit, PharmaCare, RAMQ) with your dispensing pharmacist before starting therapy.

NOTE: This page is an outline for patient-centred information and does not replace prescriber or pharmacist guidance.

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

Deciding whether to take tofranil in the morning or at night depends on how it affects your alertness and daily schedule.

Many patients in Canada prefer a bedtime dose to reduce daytime drowsiness and to take advantage of the drug’s sedating effects for sleep.

When taken twice daily, doses are generally spaced about 12 hours apart to maintain steady levels through the day and night.

Taking With Or Without Meals (Canadian Diet Context)

Taking imipramine with food can reduce stomach upset commonly reported with antidepressants.

Higher-fat Canadian meals may slow gastric emptying and absorption slightly, but this is usually clinically acceptable for most patients.

If you experience nausea or orthostatic symptoms, try taking the dose with a light snack rather than on an empty stomach.

Practical routine tips for patients on imipramine (INN: imipramine):

• Imipramine is usually given once or twice daily because of a long half-life and peak blood levels occurring 2–6 hours after a dose.
• Typical adult starting dose for depression is around 75 mg per day in divided doses, with titration as tolerated.
• Children and elderly start at lower doses; elderly patients often begin at 10–25 mg/day because of increased sensitivity.
• For those working shifts or commuting long distances, align dosing to avoid peak drowsiness during critical driving times.
• If a dose is missed, take it as soon as remembered unless it is near the next scheduled dose; do not double the dose.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Patients with a known hypersensitivity to tricyclic antidepressants should not take imipramine.

A recent myocardial infarction or serious pre-existing arrhythmia is a contraindication to using imipramine except under specialist care.

Do not use imipramine with monoamine oxidase inhibitors (MAOIs); concurrent use is contraindicated.

People with narrow-angle glaucoma, untreated urinary retention, or severe liver disease require specialist oversight before starting imipramine.

Activities To Limit (Driving, Workplace Safety)

Imipramine commonly causes drowsiness, dizziness and orthostatic hypotension, which can impair driving and operation of heavy machinery.

Wait until you know how the drug affects alertness before driving, especially during initiation and dose increases.

In rural areas plan travel carefully because sudden dizziness while driving long distances can be hazardous.

Urban commuters should be cautious on public transit during the first days of treatment if drowsiness or dizziness occurs.

Red-flag symptoms and immediate actions:

• Chest Pain or Palpitations: Call 911 immediately.
• Fainting or Severe Dizziness: Stop activity and seek emergency care.
• New Or Worsening Suicidal Thoughts: Contact your prescriber or local emergency services right away.

Dosage & Adjustments

General Regimen (DIN References)

Standard adult starting dose for major depressive disorder is approximately 75 mg per day in divided doses.

Titration may increase the total daily dose to 150–200 mg per day as tolerated, with severe cases up to 300 mg/day under specialist supervision.

Product labels and the DIN-linked product monograph give exact regimens for each marketed product; ask your pharmacist for the DIN on the dispensed package.

Tablets and capsules allow flexible titration: tablets commonly in 10 mg, 25 mg and 50 mg strengths; pamoate capsules in higher strengths up to 150 mg.

Special Cases (Elderly, Comorbidities)

Elderly patients should start low, often 10–25 mg/day, with slower increases because anticholinergic and cardiac effects can be pronounced.

Renal or hepatic impairment requires reduced dosing and closer monitoring to avoid accumulation.

For childhood nocturnal enuresis, bedtime dosing commonly starts at 10–25 mg and may be increased by age-based maxima: up to 50 mg for ages 6–12 and up to 75 mg for older adolescents.

Typical dose-by-age/condition summary:

• Adults (Depression): Start 75 mg/day divided; max 300 mg/day in severe cases.
• Elderly/Adolescents: Start 25–50 mg/day divided; adjust as tolerated.
• Nocturnal Enuresis 6–12 yrs: 25 mg at bedtime; max 50 mg/night.
• Nocturnal Enuresis >12 yrs: 25–50 mg at bedtime; max 75 mg/night.

User Testimonials

Positive Reports From Canadian Patients

Many Canadian patients report improved sleep and mood after careful titration of imipramine to 100–150 mg/day, especially when earlier SSRI therapy was insufficient.

Pharmacist support from national chains like Shoppers Drug Mart and Rexall is often credited for safer dose planning and monitoring.

Common Challenges In Forums (Reddit Canada, Health Boards)

Common adverse effects discussed on Canadian forums include daytime drowsiness, dry mouth, constipation and sexual side effects.

Rural patients sometimes experience delays in dose changes due to limited local psychiatry access and rely on virtual clinics or telepharmacy consultations.

Pros and cons from lived experience:

• Pros: Effective for some resistant depression cases and useful for enuresis when other measures fail.
• Cons: Anticholinergic effects, orthostatic hypotension, and potential cardiac monitoring requirements.
• Peer Tips: Keep a symptom diary, carry a medication card with the imipramine DIN, and ask your pharmacist about generic interchangeability.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Tofranil and generic imipramine are prescription-only products typically dispensed at major Canadian chains and reputable online Canadian pharmacies.

Check the package for the DIN and consult your pharmacist about provincial formulary listings and special-authority requirements.

Price Comparison (In-Store Vs Online, Cross-Border Notes)

Generics such as imipramine hydrochloride or imipramine pamoate are generally cheaper than branded Tofranil.

Compare in-store and online prices within Canada, but avoid dubious foreign online sellers that do not provide a Canadian DIN and licensed pharmacist contact.

Cross-border purchases from the United States may show lower prices but risk differences in formulation and importation rules; reimbursement by provincial plans is often denied for non-Canadian-sourced products.

Purchase note for our site: In our online pharmacy, tofranil is available without a prescription, with discreet delivery to Canada in 5-14 days.

What’s Inside & How It Works

Ingredients Overview

The active substance is imipramine, sold as imipramine hydrochloride (tablets 10/25/50 mg) and imipramine pamoate (capsules 75–150 mg).

Excipients vary by manufacturer; consult the product monograph on the dispensed package for allergen information.

Mechanism Basics

Imipramine is a tricyclic antidepressant that inhibits the reuptake of serotonin and norepinephrine, increasing their synaptic availability.

The ATC classification is N06AA02, reflecting non-selective monoamine reuptake inhibition.

Pharmacokinetics show peak blood levels 2–6 hours after dosing and a long half-life that allows once- or twice-daily dosing schedules.

• Active Forms: Imipramine hydrochloride (tablets), imipramine pamoate (capsules).
• Common Strengths: 10 mg, 25 mg, 50 mg (tablets); 75–150 mg (capsules).
• Mechanism: Serotonin and norepinephrine reuptake inhibition; also affects bladder control pathways for enuresis.

Main Indications

Approved Uses In Canada

Imipramine is used for major depressive disorder and for childhood nocturnal enuresis, consistent with its approval in multiple jurisdictions.

Provincial product monographs and the DIN provide the official wording for approved indications on the dispensed packaging.

Off-Label Uses By Canadian Physicians

Off-label uses may include treatment-resistant depression, chronic neuropathic pain, migraine prevention and some anxiety presentations.

Off-label prescribing should occur with informed consent and appropriate monitoring.

• Approved: Major depressive disorder; childhood nocturnal enuresis.
• Common Off-Label: Treatment-resistant depression, neuropathic pain, migraine prevention.
• Duration: Depression treatment often requires weeks to months with maintenance after response; enuresis courses are typically short-term (1–3 months) with drug-free intervals.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Avoid alcohol while taking imipramine because it increases sedation and orthostatic hypotension risk.

Caffeine can worsen anxiety or interfere with sleep but has no major pharmacokinetic interaction with imipramine.

Drug Conflicts (Health Canada Database)

Significant drug interactions include contraindicated use with MAOIs and additive risks with other QT-prolonging agents.

Anticholinergic drugs can have additive side effects when combined with imipramine, and certain antihypertensives may interact to affect blood pressure.

Herbal remedies like St. John’s wort can affect antidepressant response and should be discussed with your pharmacist.

Medications to always alert your pharmacist about:

• MAOIs (contraindicated)
• Other QT-prolonging drugs
• Anticholinergic medicines (antihistamines, some antipsychotics)
• Certain antihypertensives and antiarrhythmics
• Herbal products such as St. John’s wort

Latest Evidence & Insights

Canadian Research Highlights (Summaries)

Canadian practice tends to reserve imipramine for cases where first-line SSRIs are ineffective due to its anticholinergic and cardiac risk profile.

Clinical guidance in Canada emphasises cardiac screening such as ECG for older adults or when using high doses.

Key International Trials And Meta-Analyses

Randomized trials and meta-analyses support the efficacy of tricyclics like imipramine for severe depression, but they document a higher burden of adverse events compared with SSRIs.

Enuresis trials show short-term nightly dosing can reduce bedwetting episodes, with many protocols recommending drug-free intervals to assess ongoing need.

Clinical takeaway for prescribers: consider imipramine for treatment-resistant depression after SSRI/SNRI failure and ensure ECG and cardiology liaison when indicated.

Alternative Choices

Comparable Tricyclics And SSRIs

Alternative TCAs include amitriptyline, nortriptyline, desipramine and clomipramine.

SSRIs like fluoxetine and sertraline are generally preferred first-line for depression because of better tolerability.

Pros/Cons Checklist For Switching

Imipramine pros include effectiveness in some resistant depression cases and established use in nocturnal enuresis.

Cons include anticholinergic effects, orthostatic hypotension and cardiac risks that require monitoring.

1. Do not stop or start MAOIs without a strict washout period when switching.
2. Consider ECG if switching to or from drugs that affect the QT interval.
3. Taper slowly rather than abrupt cessation to minimise withdrawal symptoms.

Regulation Snapshot

Health Canada Approval And DIN Requirements

Imipramine/Tofranil is a prescription-only medicine regulated under Health Canada rules and marketed with a Drug Identification Number (DIN) for Canadian marketing.

Pharmacies dispense according to the DIN and the product monograph supplied with each approved product.

Provincial Drug Benefit Plan Notes

Provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ may have differing coverage rules and some require special-authority forms or limit coverage to specific indications.

FAQ Section

How Soon Will I Feel Better?

Antidepressant effects often begin in 2–6 weeks, with full benefit sometimes taking months.

For nocturnal enuresis, a bedtime dose may reduce bedwetting more quickly, but follow your prescriber's instructions.

What To Do About Side Effects And Missed Doses

Common side effects such as dry mouth, constipation and drowsiness can be managed with sugar-free gum, increased fibre and fluids, and dose timing at night.

If you miss a dose, take it as soon as you remember unless it is near the next scheduled dose; do not double the dose.

Overdose is a medical emergency and can cause seizures and serious cardiac arrhythmias; call 911 or Poison Control immediately.

• Top Questions:
• When will I feel better? 2–6 weeks for mood; monitor and report progress.
• Manage side effects: Discuss with your pharmacist for practical measures; report severe effects promptly.
• Missed dose: Take when remembered unless close to next dose; do not double up.

Guidelines For Proper Use

Canadian Pharmacist And Provincial Health Authority Recommendations

Prescribers and pharmacists should have an informed-consent conversation covering benefits, risks and monitoring expectations before starting imipramine.

Verify history of cardiac disease, glaucoma, seizures and current medications, especially MAOIs, before initiation.

Monitoring Plan And Follow-Up (ECG, BP, Side-Effect Diary)

Baseline checks often recommended for older adults or those receiving higher doses include ECG, blood pressure and assessment for urinary retention.

Follow-up within 1–2 weeks to check for side effects and again at 4–6 weeks to assess efficacy is a common schedule.

Printable monitoring plan for patients:

• Baseline: Medication list review, ECG if age or cardiac history warrants, BP and weight.
• First Follow-Up: 1–2 weeks to review adverse effects and adherence.
• Second Follow-Up: 4–6 weeks for efficacy and dose adjustments.
• Emergency Signs: Chest pain, fainting, seizures, or suicidal thoughts — call 911 immediately.
• Provincial Contacts: Ask your pharmacist about Ontario Drug Benefit, PharmaCare and RAMQ coverage and special-authority processes.

Delivery Across Canada (English)